ACHP Statement on the Announcement of the First Ten Drugs to be Negotiated in the IRA
As the only national payer organization that supported robust drug …
08/29/2023
Anticompetitive practices within the pharmaceutical industry, coupled with outdated patent laws that inhibit more affordable biosimilars and generics, have resulted in skyrocketing drug costs for all Americans – but especially seniors and those with chronic conditions. ACHP advocates for sensible policies such as price transparency to rein in sky-high costs so that patients can afford the medications they need.
As the only national payer organization that supported robust drug …
08/29/2023
ACHP commends Senate Finance Committee Chairman Ron Wyden (D-OR) and …
07/25/2023
ACHP is the only national payer group pushing for comprehensive …
06/08/2023
ACHP submitted a comment letter to USPTO with recommendations to …
02/02/2023
By offering lower costs, more benefits and better outcomes, …
01/31/2023
Morgan Health CEO Dan Mendelson joins the Healthy Dialogue podcast …
09/13/2022
ACHP applauds the Senate for passing the Inflation Reduction Act, …
08/07/2022
The Alliance of Community Health Plans has sent Congressional Leaders …
04/25/2022
ACHP responds to the Biden Administration's announcement of Medicare coverage …
04/07/2022
In his first State of the Union, President Biden recommitted …
03/02/2022
ACHP sent a letter to CMS encouraging the Administration to include policy recommendations in MA for Tomorrow in the Contract Years 2025 Part C and D Policy and Technical Changes …
09/22/2023
ACHP released a set of Frequently Asked Questions to support MA for Tomorrow, our vision for Medicare Advantage.
09/15/2023
ACHP sent a comment letter to CMS on the Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs proposed rule.
09/11/2023
ACHP submitted a letter to CMS on the STLDI proposed rule designed to support enhanced consumer experience and greater competition and efficiency in the marketplace.
09/11/2023
As the only national payer organization that supported robust drug pricing reform, including allowing direct government negotiation for drugs without competition, we are pleased by the White House’s announcement of …
08/29/2023
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.